Research Article
Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Table 1
Baseline characteristics and clinical data of the enrolled subjects.
| | Characteristics | AECOPD group () | PH group () | value |
| | Age (years) | | | 0.108 | | Gender (male), (, %) | 64 (76.19) | 77 (76.24) | 0.994 | | Hospital stay (day) | 9.00 (7.00-11.00) | 9.00 (7.00-10.00) | 0.720 | | Course of disease (year) | 10.00 (10.00-20.00) | 10.00 (10.00-20.00) | 0.537 | | BMI (kg/m2) | | | 0.095 | | Smoking index (year root) | 600 (200-800) | 600 (200-1000) | 0.322 | | Hypertension (, %) | 35 (41.67) | 36 (35.64) | 0.402 | | Diabetes (, %) | 11 (13.10) | 11 (10.89) | 0.645 | | NYHA classification (, %) | | | | | I | 29 (34.52) | 7 (6.93) | | | II | 45 (53.57) | 37 (36.63) | | | III | 10 (11.91) | 48 (47.53) | | | IV | 0 | 9 (8.91) | |
|
|
Abbreviations: AECOPD—acute exacerbation of chronic obstructive pulmonary disease; PH—pulmonary hypertension; BMI—body mass index; NYHA—New York Heart Association.
|
